Elicit AI Review 2026: Pricing, Research & Systematic Reviews

Elicit is an AI research assistant built for scientific literature, evidence synthesis and systematic review workflows rather than general-purpose web search. Its current product can search more than 138 million academic papers, query ClinicalTrials.gov, analyze uploaded documents, create source-linked reports, screen studies, extract structured data and help teams maintain auditable review processes.

The product has become more ambitious in 2026 with Research Agent. Instead of only returning papers or summarizing abstracts, Research Agent can plan multi-step research, search across scientific and structured sources, inspect figures and tables, analyze data and produce research outputs while linking claims back to the evidence used.

Elicit's main advantage is traceability. The company emphasizes sentence-level support for AI-generated claims and structured review steps with explicit inclusion decisions, exclusion reasons and extraction evidence. That makes it more suitable for high-stakes research than a chatbot answer that provides only a general bibliography.

What is Elicit?

Elicit is a web-based AI research environment focused on finding, evaluating, extracting and synthesizing scientific evidence. It is not primarily a writing assistant. The product is designed to help researchers move from a question to a defensible evidence base while preserving links between AI-generated outputs and underlying sources.

Core surfaces include Paper Search, Research Agent, Research Reports, Systematic Review Workflow, extraction tables, Alerts, a research library, Zotero import and API access. The platform is used in academia, pharmaceutical research, medtech, policy, consumer research and other evidence-heavy fields.

Who should use Elicit?

Elicit is best suited to researchers who repeatedly work with scientific literature. Graduate students can use it to map a field and compare studies. Clinical and policy researchers can use structured screening and extraction to accelerate reviews. R&D teams can use Research Agent to investigate targets, competitors, trials and mechanistic evidence. Systematic-review teams can use the dedicated workflow to make screening and extraction more auditable.

It can also be useful for analysts who are not formal academics but need source-backed scientific evidence. A product team evaluating a health claim, an investment team researching a biomedical market or a regulatory group mapping clinical evidence can use Elicit to reduce the manual work of discovering and organizing relevant sources.

Elicit is a weaker fit for general current-events research, broad web discovery, creative writing or casual question answering. Its value comes from scientific evidence and traceability. Users who rarely need academic papers may find a general research assistant more flexible.

How we evaluated Elicit

Paper Search

Elicit's Paper Search gives users an easier starting point than constructing complex database syntax. Researchers can use natural-language or structured search approaches and then inspect papers, summaries and extracted information. The Basic plan currently includes unlimited search across more than 138 million papers.

Semantic search is useful for exploratory discovery because researchers do not need to know every keyword used by a field before beginning. For formal systematic reviews, however, reproducible keyword strategies and database-specific searches remain important. Elicit's review workflow supports combining semantic discovery with reproducible searches and imported records.

Research Agent

Research Agent is the newest major evolution of Elicit. It is designed to handle research questions that require more than a single retrieval step. The current product page says the agent can search literature, extract data, analyze figures and tables, model data and create charts while showing how it planned and executed the work.

The most important design choice is evidence traceability. Elicit says every claim can link back to the supporting passage, table or figure. That does not eliminate hallucination risk, but it makes verification easier because the researcher can inspect the exact evidence rather than search a full paper for the sentence that supposedly supports a claim.

Research Agent also works across several source classes. Current documentation lists academic papers, ClinicalTrials.gov, uploaded documents, structured biological databases and other public or proprietary sources depending on the workflow and account.

Research Reports

Research Reports turn a question into a structured evidence synthesis. Paid tiers increase how many data sources a report can extract from: current Pro documentation lists up to 135 data sources, while Scale increases that to 200.

Reports are valuable for scoping a topic, identifying disagreements and preparing evidence for deeper analysis. They should not automatically be treated as formal systematic reviews. A formal review still needs an explicit protocol, comprehensive search strategy, screening criteria and documented extraction process.

Systematic Review Workflow

Elicit's Systematic Review Workflow is one of its clearest differentiators. The workflow covers protocol refinement, source gathering, screening, data extraction and evidence synthesis. Users can search Elicit's paper corpus, PubMed and ClinicalTrials.gov, and can import records from external databases.

Current Pro capacity supports screening up to 5,000 papers. Enterprise can scale to 40,000. Elicit autosuggests screening criteria and inclusion recommendations, but users can edit the criteria and make final decisions. The workflow retains exclusion reasons, per-criterion scores and supporting quotes so decisions are auditable.

Elicit also supports dual-review approaches in which two human reviewers work with AI assistance or AI acts as the second reviewer. That can reduce screening labor, but organizations should validate the workflow against their methodological and regulatory requirements before substituting AI for a human reviewer.

Data extraction

Structured extraction is where Elicit moves beyond a research chatbot. Researchers can define columns such as population, intervention, sample size, outcome, effect estimate or limitation and have Elicit extract those fields across papers. Pro currently supports adding 20 columns at a time, Scale 30 and Enterprise 40.

Elicit emphasizes source support for extracted values, including quotes or figures from the paper. The company publishes internal and customer validation data showing high extraction accuracy in selected evaluations. Those figures are useful evidence about the system, but they should not be assumed to guarantee identical accuracy in every domain, document format or study design.

PRISMA and auditability

Formal literature reviews require more than a final answer. Researchers need to know what was searched, which studies were excluded and why, and how data moved from papers into the synthesis. Elicit's systematic-review workflow is designed around that audit trail.

The product can generate methods information and PRISMA-oriented outputs, including flow information, paper-summary tables and search strategies. This makes Elicit more appropriate for research teams that need to defend the process, not just consume the result.

ClinicalTrials.gov and scientific data sources

Research Agent currently documents real-time access to more than 545,000 ClinicalTrials.gov records. It also lists structured biological sources such as Open Targets, ChEMBL and DepMap, alongside the academic-paper corpus.

These sources are especially useful in pharmaceutical, biotech and clinical research because published papers are only one part of the evidence landscape. A registered trial, patent or structured target database can provide information that is not yet visible in peer-reviewed literature.

Zotero and uploaded documents

Elicit can import references from Zotero and supports user-provided files such as PDFs and common citation-library formats. This helps researchers bring an existing corpus into the same environment rather than restarting discovery from scratch.

Full-text access still depends on rights and availability. Importing a citation does not automatically give Elicit legal access to every publisher's full paper. Institutions should connect permitted sources and subscriptions where supported.

Alerts and living reviews

Pro currently includes up to ten personalized research Alerts, while Enterprise lists unlimited paper alerts. Alerts are useful for living systematic reviews or fast-changing fields because the team can monitor new papers after the initial review is complete.

A living review still needs governance. New evidence should be screened under the same inclusion criteria, extracted consistently and integrated into the synthesis. Alerts automate discovery, not the methodological decision about whether a new study changes the conclusion.

API access

Pro includes API access, and Enterprise currently advertises unlimited Search API access. This lets organizations integrate Elicit's scientific search capabilities into internal research systems, dashboards and evidence workflows.

Programmatic access is most useful when the organization already has a repeatable process. API availability does not solve poor review design. Teams should define query templates, validation steps, logging and source retention before automating evidence retrieval at scale.

Pricing overview

Elicit's live pricing page currently renders multiple audience and billing states. In addition to the $132/$468/$1,068 annual set, the page also exposes alternate self-serve states where Pro is $588 annually and Scale is $2,028 annually. Because of this, SearchSagar does not present one universal month-to-month price for every buyer.

The correct practice is to verify the audience and billing state shown in checkout before purchase. The Free plan is unambiguous, while Enterprise remains custom.

Cancellation and refunds

Elicit's individual Terms say paid subscriptions can generally be canceled at any time. Cancellation stops future renewal, while the subscription remains active until the end of the current paid term and then reverts to the free account.

Amounts already paid are generally non-refundable, except when Elicit terminates or discontinues a qualifying paid service or applicable law requires otherwise. Buyers comparing annual tiers should therefore validate plan fit before committing to a year.

Security and enterprise controls

Elicit publishes Terms, Privacy Policy and a Data Processing Addendum. Enterprise pricing lists SSO/SAML, 2FA, domain verification, user analytics and custom deployment options such as single-tenancy. The live pricing page also states that Enterprise data is not used for training by default.

SearchSagar did not find a formal public certification page in the reviewed source set comparable to vendors that prominently publish SOC 2 or ISO certificates. That does not mean Elicit lacks appropriate security; it means enterprise buyers should request the current security package during procurement rather than assume certification status.

No verified G2 rating used

SearchSagar did not use a G2 rating for this review because a clearly matching current G2 profile with reliable review volume was not confirmed for the present Elicit product. This avoids importing reviews from a similarly named or historically mismatched listing.

The absence of a large independent review corpus makes direct evaluation more important. Basic is useful for testing search and summaries, while organizations considering Pro, Scale or Enterprise should run a representative literature-review task before signing a larger commitment.

How Elicit fits into a real systematic-review team

Elicit is most useful when the team decides which parts of the review can be accelerated and which parts remain human-governed. A practical workflow can use Elicit to refine search strategies, deduplicate or organize records, generate preliminary screening recommendations, extract repeated study fields and build source-linked tables. Human reviewers then resolve ambiguous eligibility decisions, assess risk of bias and approve the final interpretation.

This division of labor is important because automation changes where mistakes can occur. Manual reviews risk fatigue and inconsistent extraction; AI-assisted reviews risk systematic misclassification at scale. A team should therefore validate a sample of Elicit's decisions early, record disagreement rates and tighten instructions before processing thousands of papers.

Living reviews and ongoing evidence monitoring

Elicit's Alerts and reusable projects make it suitable for living reviews that need periodic updates. Once a review is complete, researchers can monitor new publications and apply the same eligibility logic to incoming studies rather than rebuilding the process from scratch.

The efficiency gain is largest when the protocol is stable. If inclusion criteria, outcomes or research questions change materially, the team may need to revisit earlier screening and extraction. Living review automation should therefore preserve versioned protocols and dates so readers can understand which evidence was evaluated under which criteria.

Pros and cons

SearchSagar rating

The 4.5 SearchSagar score reflects Elicit's excellent scientific-research feature depth and strong source traceability. Pricing/value scores lower because the public page exposes multiple audience states, while integrations/security is slightly more conservative because no formal public certification page was confirmed during this research pass.

Elicit versus major alternatives

Consensus is stronger when the main workflow is conversational question-to-evidence research with a lower-cost Pro plan and simple Deep Reviews. SciSpace is broader for PDF analysis, systematic reviews, extraction tables and cited writing in one workspace. Scite is strongest when citation context matters—whether later literature supports, contrasts with or merely mentions a paper.

Elicit remains particularly strong when a team needs structured systematic-review screening and extraction with auditable source evidence.

Final verdict

Elicit is one of the strongest research-specific AI products for teams that care about evidence traceability and systematic methodology. Its combination of semantic discovery, structured review workflows, extraction tables and source-linked synthesis goes well beyond generic AI research chat.

The product is most valuable when the research process itself matters as much as the answer. Buyers should verify pricing at checkout, validate AI decisions and continue treating original papers as the final evidence source.

Frequently asked questions